Insider Transactions in Q1 2021 at Phreesia, Inc. (PHR)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 16
2021
|
David Linetsky SVP, Life Sciences |
SELL
Open market or private sale
|
Direct |
1,578
-0.56%
|
$94,680
$60.15 P/Share
|
|
Mar 15
2021
|
David Linetsky SVP, Life Sciences |
SELL
Open market or private sale
|
Direct |
48,482
-17.97%
|
$2,957,402
$61.38 P/Share
|
|
Feb 19
2021
|
Thomas Altier Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
904
-0.55%
|
$65,992
$73.03 P/Share
|
|
Feb 18
2021
|
Thomas Altier Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
76,272
-18.32%
|
$5,491,584
$72.55 P/Share
|
|
Feb 18
2021
|
Edward L Cahill Director |
SELL
Open market or private sale
|
Direct |
10,000
-4.84%
|
$720,000
$72.63 P/Share
|
|
Jan 29
2021
|
Amy Beth Van Duyn SVP, Human Resources |
SELL
Open market or private sale
|
Direct |
21,829
-8.08%
|
$1,440,714
$66.28 P/Share
|
|
Jan 29
2021
|
Amy Beth Van Duyn SVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
18,204
+10.06%
|
$0
$0.84 P/Share
|
|
Jan 22
2021
|
Thomas Altier Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,495
-0.47%
|
$103,155
$69.7 P/Share
|
|
Jan 20
2021
|
David Linetsky SVP, Life Sciences |
SELL
Open market or private sale
|
Direct |
6,826
-2.29%
|
$443,690
$65.5 P/Share
|
|
Jan 20
2021
|
Chaim Indig Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
14,892
-0.44%
|
$967,980
$65.83 P/Share
|
|
Jan 20
2021
|
Chaim Indig Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,892
+1.29%
|
$59,568
$4.71 P/Share
|
|
Jan 19
2021
|
Michael Weintraub Director |
SELL
Open market or private sale
|
Direct |
35,000
-9.2%
|
$2,205,000
$63.86 P/Share
|
|
Jan 19
2021
|
Michael Weintraub Director |
BUY
Exercise of conversion of derivative security
|
Direct |
35,000
+14.93%
|
$70,000
$2.03 P/Share
|
|
Jan 19
2021
|
Evan Roberts Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,500
-0.45%
|
$352,000
$64.08 P/Share
|
|
Jan 19
2021
|
Chaim Indig Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
59,986
-2.55%
|
$3,779,118
$63.74 P/Share
|
|
Jan 19
2021
|
Chaim Indig Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
59,986
+4.82%
|
$119,972
$2.03 P/Share
|
|
Jan 19
2021
|
David Linetsky SVP, Life Sciences |
SELL
Open market or private sale
|
Direct |
5,136
-3.32%
|
$328,704
$64.28 P/Share
|
|
Jan 19
2021
|
Thomas Altier Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,704
-2.86%
|
$301,056
$64.0 P/Share
|
|
Jan 17
2021
|
Evan Roberts Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
872
-0.14%
|
$54,064
$62.96 P/Share
|
|
Jan 17
2021
|
Chaim Indig Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
25,073
-2.18%
|
$1,554,526
$62.96 P/Share
|
|
Jan 17
2021
|
Amy Beth Van Duyn SVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
334
-0.6%
|
$20,708
$62.96 P/Share
|
|
Jan 17
2021
|
David Linetsky SVP, Life Sciences |
SELL
Payment of exercise price or tax liability
|
Direct |
277
-0.18%
|
$17,174
$62.96 P/Share
|
|
Jan 17
2021
|
Thomas Altier Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
780
-0.47%
|
$48,360
$62.96 P/Share
|
|
Jan 15
2021
|
Allison C Hoffman General Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
19,059
+18.06%
|
-
|
|
Jan 15
2021
|
Evan Roberts Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,496
-0.73%
|
$278,752
$62.96 P/Share
|
|
Jan 15
2021
|
Evan Roberts Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,589
+4.45%
|
-
|
|
Jan 15
2021
|
Chaim Indig Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,138
-0.62%
|
$442,556
$62.96 P/Share
|
|
Jan 15
2021
|
Chaim Indig Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
55,590
+4.58%
|
-
|
|
Jan 15
2021
|
Chaim Indig Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
75,122
-2.17%
|
$4,657,564
$62.49 P/Share
|
|
Jan 15
2021
|
Chaim Indig Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
75,122
+6.0%
|
$150,244
$2.03 P/Share
|
|
Jan 15
2021
|
Amy Beth Van Duyn SVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
1,005
-1.76%
|
$62,310
$62.96 P/Share
|
|
Jan 15
2021
|
Amy Beth Van Duyn SVP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
12,706
+18.24%
|
-
|
|
Jan 15
2021
|
David Linetsky SVP, Life Sciences |
SELL
Payment of exercise price or tax liability
|
Direct |
1,787
-1.14%
|
$110,794
$62.96 P/Share
|
|
Jan 15
2021
|
David Linetsky SVP, Life Sciences |
BUY
Grant, award, or other acquisition
|
Direct |
28,589
+15.43%
|
-
|
|
Jan 15
2021
|
Thomas Altier Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,604
-1.55%
|
$161,448
$62.96 P/Share
|
|
Jan 15
2021
|
Thomas Altier Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,147
+4.09%
|
-
|
|
Jan 05
2021
|
Evan Roberts Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
21,468
-1.78%
|
$1,137,804
$53.6 P/Share
|
|
Jan 05
2021
|
Evan Roberts Chief Operating Officer |
SELL
Exercise of conversion of derivative security
|
Direct |
575
-0.09%
|
$2,300
$4.71 P/Share
|
|
Jan 04
2021
|
Amy Beth Van Duyn SVP, Human Resources |
SELL
Open market or private sale
|
Direct |
500
-1.12%
|
$27,000
$54.26 P/Share
|
|
Jan 04
2021
|
Amy Beth Van Duyn SVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+1.1%
|
$0
$0.84 P/Share
|
|
Jan 04
2021
|
Mark Douglas Smith Director |
SELL
Open market or private sale
|
Direct |
6,000
-19.68%
|
$318,000
$53.02 P/Share
|
|
Jan 04
2021
|
Mark Douglas Smith Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+33.13%
|
$24,000
$4.71 P/Share
|
|
Jan 04
2021
|
Evan Roberts Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
80,245
-3.03%
|
$4,252,985
$53.06 P/Share
|